BRCA Germline Mutations in an Unselected Nationwide Cohort of Chinese Patients With Ovarian Cancer and Healthy Controls

Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2018.07.024
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

BRCA Mutations in the Manifestation and Treatment of Ovarian Cancer

Oncotarget
Oncology
2017English

UK BRCA Mutation Testing in Patients With Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

Novel Germline Mutations and Unclassified Variants of BRCA1 and BRCA2 Genes in Chinese Women With Familial Breast/Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Germline and Somatic Mutations of Homologous Recombination-Associated Genes in Japanese Ovarian Cancer Patients

Scientific Reports
Multidisciplinary
2019English

Germline BRCA, Chemotherapy Response Scores, and Survival in the Neoadjuvant Treatment of Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Germline MUTYH Gene Mutations Are Not Frequently Found in Unselected Patients With Papillary Breast Carcinoma

Hereditary Cancer in Clinical Practice
OncologyGenetics
2014English

Novel Germline CDK4 Mutations in Patients With Head and Neck Cancer

Hereditary Cancer in Clinical Practice
OncologyGenetics
2012English

Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients With Pancreatic Cancer

Gastroenterology
HepatologyGastroenterology
2015English

Phase 1 Trial of Olaparib and Oral Cyclophosphamide in BRCA Breast Cancer, Recurrent BRCA Ovarian Cancer, Non-Brca Triple-Negative Breast Cancer, and Non-Brca Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy